StocksRunner logo
mail
search
 
menu
 
AbbVie
$226.87
+0.21%
 
  Create Alerts  
  
  Overview  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
  
  Headlines  
 
 
 
 

ABBV

 

AbbVie

$226.87

 
+$0.47 | +0.21%
 
  Create Alerts  
  
  Overview  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
  
  Headlines  
 
 
52W High
$ 244.81
 
 
MKT CAP
$ 400.78B
 
52W Low
$ 163.81
 
 
VOL
$ 2.94M
 
P/E Ratio
107.97
 
 
AVG VOL
$ 6.13M
 
RSI
53.24
 
 
TREND
Uptrend
 
 
 

ABBV Stock IQ

 
lock  Login to see AbbVie (ABBV) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 

ABBV Target Price

 
 
 

Strengths

 

ABBV Rewards

 Earnings are forecast to grow

ABBV Rewards

 Trading below its fair value

ABBV Rewards

 Investors confidence is positive

ABBV Rewards

 Pays a reliable dividend

 

Technical Indicators

 

ABBV Technical Indicators

 5+ Days Down

 
 

Chart

 
 

$222.47   (+1.98%)

$190.83   (+18.89%)

$185.72   (+22.16%)

$201.5   (+12.59%)

 
 
1year
6month
3month
1month
 

ABBV Risk Level

 

ABBV has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

 
 

Risks Indicators

 

 Investors losing confidence

 
 
ABBV Risk Level
LOW
HIGH
 

ABBV Analysts Opinion

 

ABBV overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

 
 

Earnings

×
 

Earnings

 

ABBV Earnings Sentiment

 Reported a strong earnings

ABBV Earnings Sentiment

 Above analyst estimates

ABBV Earnings Sentiment

 Revenue increase YoY

ABBV Earnings Sentiment

 Earnings increase YoY

 
 

Rating

×
 

Rating

 

ABBV Rating Sentiment

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

 

ABBV Momentum Analysis

 Has been gaining momentum

 

Activity

×
 

Activity

 

ABBV Activity Sentiment

 Investors confidence is positive

ABBV Activity Sentiment

 Pays a reliable dividend

 

Future

×
 

Future

 

ABBV Future Sentiment

 Earnings are forecast to grow

ABBV Future Sentiment

 Trading below its fair value

 
 

ABBV Analysts Opinion

ABBV Analysts opinion is positive but there was a setback from the past 3 months

 

ABBV Street Consensus

 

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
81%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
33%
17%
89%
 

ABBV Street Opinion 

ABBV Street view is extremely bullish and have positive views on the near-term outlook

 

ABBV Performance Sentiment

 
Sentiments overview associated with ABBV events and the stock performance.
 
81%
14%
Positive
Negative
48 out of 59
events present
8 out of 59
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
 

Technical Price Levels

 

Average key support and resistance price levels.

 
lock  Login to display
 
Support
Price
 
$226.22
 
Resistance
Price
 
$212.84
 
 
Current Price Range
 
$244.38
 
 
Show methods +
 
 
 
Linked to ABBV
IQ
Close Price
Change

 

PFE

4.14

24.23

-0.70%

 

NVS

4.28

130.77

+0.58%

 

LLY

4.22

819.38

-0.90%

 

SNY

4.31

50.02

+2.17%

 

TEVA

2.52

19.63

-0.76%

 
 
 
ABBV Latest Analysis +
 
 
FAQ About ABBV Stock Insights
 

What is ABBV current stock price?

What are ABBV stock strengths?

What risks are associated with ABBV stock?

When is ABBV next earnings report?

What is ABBV market cap and volume?

What is ABBV's current Stock IQ?

Should I buy ABBV stock right now?

Is ABBV a Strong Buy right now?

What does a 'Strong Buy' rating mean for ABBV?

What does a 'Strong Sell' rating mean for ABBV?

What factors influence ABBV's Stock IQ?

 
 
StocksRunner

Explore our ABBV Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored ABBV Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our ABBV Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
StocksRunner
 
 
StocksRunner Overview
 
StocksRunner Trending
 
StocksRunner Screener
 
StocksRunner Insights
 
StocksRunner Top Rated
 
StocksRunner Momentum
 
StocksRunner Earnings
 
StocksRunner Leaders
mail
 
 

ABBV

 

AbbVie

 
 

Current Price

 

$226.87

 
+$0.47 | +0.21%
 
 
52W High
$ 244.81
 
 
MKT CAP
$ 400.78B
 
52W Low
$ 163.81
 
 
VOL
$ 2.94M
 
P/E Ratio
107.97
 
 
AVG VOL
$ 6.13M
 
RSI
53.24
 
 
TREND
Uptrend
 
 
 
  Create Alerts  
  
  Overview  
  
  Insights  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
 
 
 
 

Target Price

 
 
 
 
Not Enough Information
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 

ABBV Rewards

 Earnings are forecast to grow

ABBV Rewards

 Trading below its fair value

ABBV Rewards

 Investors confidence is positive

ABBV Rewards

 Pays a reliable dividend

 

Technical Indicators

 

ABBV Technical Indicators

 5+ Days Down

 
 
 
 
 

ABBV Stock IQ

 
lock  Login to unlock AbbVie (ABBV) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 

Chart

 
 

$222.47   (+1.98%)

$190.83   (+18.89%)

$185.72   (+22.16%)

$201.5   (+12.59%)

 
 
1year
6month
3month
1month
 

ABBV Analysts Opinion

 

ABBV Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

 
 

Earnings

×
 

Earnings

 

ABBV Earnings Sentiment

 Reported a strong earnings

ABBV Earnings Sentiment

 Above analyst estimates

ABBV Earnings Sentiment

 Revenue increase YoY

ABBV Earnings Sentiment

 Earnings increase YoY

 
 

Rating

×
 

Rating

 

ABBV Rating Sentiment

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

 

ABBV Momentum Sentiment

 Has been gaining momentum

 

Activity

×
 

Activity

 

ABBV Activity Sentiment

 Investors confidence is positive

ABBV Activity Sentiment

 Pays a reliable dividend

 

Future

×
 

Future

 

ABBV Future Sentiment

 Earnings are forecast to grow

ABBV Future Sentiment

 Trading below its fair value

 
 

ABBV Analysts Opinion

ABBV Analysts opinion is positive but there was a setback from the past 3 months

 

ABBV Street Consensus

 

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
81%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
33%
17%
89%
 

ABBV Street Opinion 

ABBV Street view is extremely bullish and have positive views on the near-term outlook

 

ABBV Risk Level

 

ABBV has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

 
 

Risks Indicators

 

 Investors losing confidence

 
 
ABBV Risk Level
LOW
HIGH
 
ABBV Performance Sentiment
 
Sentiments overview associated with ABBV events and the stock performance.
 
81%
14%
Positive
Negative
48 out of 59
events present
8 out of 59
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

Technical Price Levels

 

Average key support and resistance price levels.

 
lock  Login to display
 
Support
Price
 
$226.22
 
Resistance
Price
 
$212.84
 
 
Current Price Range
 
$244.38
 
 
Show methods +
 
 
 
 
 
 
 

ABBV Latest Analysis

 
 
 

Cantor Fitzgerald Reaffirms Overweight Rating on AbbVie (ABBV). AbbVie Inc. (NYSE:ABBV) is included among the 11 Defensive Healthcare Dividend Stocks to Buy Now. A global pharmaceutical company AbbVie Inc. (NYSE:ABBV) is among the best dividend stocks in the healthcare sector. On October 14 C‍antor Fitzgerald reaffirmed⁠ its Overwe⁠ight rating a⁠nd $2‍5⁠0 price targ⁠et‌ f‍or AbbVie Inc. (NYSE:ABBV) while revising its earnings model⁠ to [….]

 

Today

$226.87 | +0.21%
 
Rating

AbbVie (ABBV) Stock Falls Amid Market Uptick: What Investors Need to Know. The latest trading day saw AbbVie (ABBV) settling at $226.22 representing a -1.27% change from its previous close.

 

Wed Oct 15, 2025

$226.22 | -0.56%
 
Momentum

Can Rinvoq and Skyrizi Sales Drive Another Strong Quarter for AbbVie?. ABBV leans on booming Skyrizi and Rinvoq-driven sales to sustain growth and counter Humiras decline as Q3 results approach.

 

Tue Oct 14, 2025

$229.13 | -0.51%
 
Earnings

AbbVie Gets FDA Approval To Expand RINVOQ Use For Ulcerative Colitis And Crohns Disease . (RTTNews) - AbbVie (ABBV) Monday announced the United States Food and Drug Administration (FDA) approval of a supplemental new drug application (sNDA) that updates the indication statement for RINVOQ (upadacitinib) for the treatment of adults with moderately to severely active ulcerative

 

Mon Oct 13, 2025

$230.30 | -0.13%
 
Activity

Ex-Dividend Reminder: Abbott Laboratories AbbVie and ARMOUR Residential REIT . Looking at the universe of stocks we cover at Dividend Channel on 10/15/25 Abbott Laboratories (Symbol: ABT) AbbVie Inc (Symbol: ABBV) and ARMOUR Residential REIT Inc. (Symbol: ARR) will all trade ex-dividend for their respective upcoming dividends. Abbott Laboratories will

 

Mon Oct 13, 2025

$230.30 | -0.13%
 
Activity

AbbVie to Present New Data at ESMO 2025 Reinforcing Leadership in Advancing Targeted Therapies for Solid Tumors. New data from telisotuzumab adizutecan (Temab-A) and ABBV-706 across pancreatic colorectal and solid tumors highlight progress in AbbVies growing ADC portfolio designed to target difficult-to-treat cancers. NORTH CHICAGO Ill. Oct. 13 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today...

 

Mon Oct 13, 2025

$230.30 | -0.13%
 
Activity

Carolina Wealth Trims Its AbbVie Stake to Nearly Nothing. Key PointsCarolina Wealth Advisors sold 38267 AbbVie shares. estimated transaction value ~$7.79 million based on quarterly average price

 

Thu Oct 9, 2025

$230.69 | -0.24%
 
Activity

Cantor Fitzgerald raises Abbvie stock price target to $250 on strong Skyrizi performance.

 

Thu Oct 9, 2025

$230.69 | -0.24%
 
Earnings
Potential

Cramers Absolute Favorite AbbVie Rises After Study Completions and Upgrade. AbbVie Inc. (NYSE:ABBV) is one of Jim Cramers Recession-Proof Stock Picks. Cramer calls the stock his absolute favorite and it is followed by updates on the completion of two key studies. At the beginning of this month AbbVie Inc. (NYSE:ABBV) announced the completion of a key study on ABBV-101s food interaction and a Phase 2 [….]

 

Wed Oct 8, 2025

$231.24 | -0.70%
 
Momentum

AbbVie Inc. (ABBV) Starts Building $70 Million Expansion of Its AbbVie Bioresearch Centre in Worcester Massachusetts. With significant hedge fund interest and trending on Reddit AbbVie Inc. (NYSE:ABBV) secures a spot on our list of the 10 Best Non-Tech Stocks to Buy According to Reddit. As part of its $10 billion United States capital expenditure strategy to increase biologics manufacturing capacity AbbVie Inc. (NYSE:ABBV) started building a $70 million expansion of its [….]

 

Wed Oct 8, 2025

$231.24 | -0.70%
 
Activity
Potential

 
 
 
 
 
StocksRunner

Discover ABBV Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of ABBV. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our ABBV Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

ABBV Stock trends

ABBV Stock performance

ABBV Stock analysis

ABBV investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 

ABBV Runner Alarm

Real-time signals powered by data
×

Price-Based

Triggers when the stock breaks through a known resistance level
 
Triggers when the stock drops below a key support level
 
Notifies if the stock moves up/down by a set percentage (e.g. ±5%)
 
Alerts when the stock hits a new high or low
 
Signals proximity to long-term highs or lows (e.g. within 5%)
 

Technical Indicator (Pro Plan)

Volume spikes 2x–3x above average. Indicates strong buying/selling pressure
 
Tracks large intraday swings, signaling potential opportunities or risk
 
Signals potential trend reversals or continuations
 
Long-term bullish/bearish trend signals from MA crossovers
 
RSI above 70 or below 30 to identify possible reversals
 
Signals momentum shifts
 

Fundamental (Master Plan)

Upcoming or just-released earnings reports
 
Alerts after results compared to expectations
 
Changes in rating or target price
 
New or changed dividends
 
Large trades by company insiders
 
M&A, lawsuits, product launches, etc
 
High volume/open interest in call/put contracts
 
Surge in mentions or sentiment shifts
 

 
 
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing ABBV

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

 
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing ABBV

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.